🇺🇸 FDA
Patent

US 6217864

Method for targeted degradation of intracellular proteins in vivo or ex vivo

expired A61KA61K38/00A61P

Quick answer

US patent 6217864 (Method for targeted degradation of intracellular proteins in vivo or ex vivo) held by The Regents of the University of California expires Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 17 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00, A61P, A61P35/00